Search Articles
Search results
Displaying 1 - 20 of 2215
Cancer,
Science & Research
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients
The FDA approval was based on results of the QUILT 3.032 clinical trial, which was led by Dr. Karim Chamie, associate professor urology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Health Jonsson Comprehensive Cancer Center.
April 23, 2024
|
3 min read
Science & Research
Treatment from female doctors leads to lower mortality and hospital readmission rates
Patients have lower rates of mortality and hospital readmissions when treated by female physicians, with female patients benefitting more than their male counterparts.
April 22, 2024
|
3 min read
Cancer
Danielle Siegel helps patients process mortality, what's important in life, after a cancer diagnosis.
April 19, 2024
|
3 min read
Cancer,
Science & Research
Mutations in noncoding DNA become functional in some cancer-driving genes
UCLA researchers, using an experiment that elucidated the function of tens of thousands of noncoding variants, discovered a link between functional mutations and genes linked to cancer pathways, as well as indicators to predict cancer patient survival.
April 18, 2024
|
5 min read
Cancer,
Science & Research
Cancer researchers receive Team Science Award from Melanoma Research Alliance
The award supports the team’s research in improving a small molecule to break down PD-L1 more effectively and identifying other PD-L1-degrading small chemical compounds.
April 16, 2024
|
2 min read
News about UCLA Health
The UCLA Center for Human Nutrition celebrates its 30th anniversary
The UCLA Center for Human Nutrition at UCLA Health celebrated its 30th anniversary on Saturday, April 13, and recognized the center’s achievements in nutrition research and clinical care.
April 16, 2024
|
2 min read
Cancer,
Science & Research
Advance in immune cell screening uncovers receptors that target prostate cancer
A recent UCLA study demonstrates a new process for screening T cells, part of the body’s natural defenses, for characteristics vital to the success of cell-based treatments.
April 15, 2024
|
4 min read
Cancer
Dr. Beth Karlan named NCCN Guidelines Steering Committee Chair
In this role, Karlan, director of cancer population genetics at the UCLA Health Jonsson Comprehensive Cancer Center, is responsible for overseeing the development, maintenance, and dissemination of clinical practice guidelines for cancer care.
April 12, 2024
|
2 min read
Science & Research
Migraine treatments: What are the latest advances?
Recent research has led to a new class of medications
April 12, 2024
|
3 min read
Cancer,
Science & Research
Dr. Matthew Rettig recognized by VA for contributions to prostate cancer research
The award recognizes Rettig’s commitment to improving health care for veterans, as well as his scientific leadership. Along with the honor, Rettig will receive $150,000 over the next three years in research support.
April 11, 2024
|
2 min read
Science & Research
When wildfire smoke affects air quality, even healthy adults should stay indoors, UCLA Health pulmonologist says
'A big part of the danger of wildfire pollution is the intensity of the exposure,' says UCLA Health pulmonologist Dr. May-Lin Wilgus.
April 11, 2024
|
4 min read
Cancer,
Science & Research
Black women with breast cancer are less likely than white women to undergo preventative removal of the unaffected breast
Black women with cancer in one breast are less likely than white women to undergo contralateral prophylactic mastectomies (CPM), a procedure to remove the unaffected breast, which women often choose for deeply personal reasons.
April 11, 2024
|
3 min read
News about UCLA Health
UCLA receives $5 million grant to align neuroscience and societal needs
April 10, 2024
|
2 min read
Science & Research
‘Deaths of despair’ among Black Americans surpassed those of white Americans in 2022
April 10, 2024
|
3 min read
Cancer,
Science & Research
Researchers receive $10.2 million from CIRM to advance CAR T-cell therapy for aggressive cancers
The award supports the team’s work investigating a new immunotherapy treatment using CAR T-cells to treat patients whose tumors express a protein called IL13Ra2.
April 10, 2024
|
2 min read
Science & Research
Patient portal vs. text message: Could text reminders help you stay current on your vaccines?
A UCLA Health study aimed to determine whether receiving text reminders to receive routine influenza vaccination was more effective than patient portal reminders. However, researchers found neither text messages nor portal-based messages significantly increased influenza vaccination rates.
April 9, 2024
|
3 min read
Science & Research
A gene mutation associated with a rare neurological disorder and increased susceptibility to viral infections may be treatable with oleic acid
A mutation in a protein regulating natural killer (NK) cells’ function is at the root of immune deficiency in some people with a rare genetic condition characterized by cognitive and developmental delay, seizures, and other manifestations.
April 9, 2024
|
3 min read
Science & Research
This common pesticide may have a link to Parkinson’s disease, study says
Researchers from UCLA looked at patients in California’s Center Valley.
April 8, 2024
|
2 min read
Cancer,
Science & Research
AACR: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer
A pilot study led by UCLA investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug in combination with chemotherapy before surgery is safe and may improve long-term outcomes.
April 5, 2024
|
4 min read
News about UCLA Health,
Science & Research
Feeding the lonely brain
A new study has found that women who perceive themselves to be lonely exhibited activity in regions of the brain associated with cravings and motivation towards eating especially when shown pictures of high calorie foods such as sugary foods.
April 4, 2024
|
3 min read